Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$53.26 - $77.18 $910,905 - $1.32 Million
-17,103 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$57.51 - $75.36 $450,878 - $590,822
-7,840 Reduced 31.43%
17,103 $1.29 Million
Q2 2020

Aug 13, 2020

SELL
$32.91 - $59.82 $3,192 - $5,802
-97 Reduced 0.39%
24,943 $1.49 Million
Q1 2020

May 13, 2020

SELL
$26.79 - $38.99 $4,259 - $6,199
-159 Reduced 0.63%
25,040 $874,000
Q4 2019

Feb 14, 2020

SELL
$29.07 - $35.63 $37,093 - $45,463
-1,276 Reduced 4.82%
25,199 $732,000
Q3 2019

Nov 14, 2019

BUY
$28.19 - $41.75 $725,892 - $1.08 Million
25,750 Added 3551.72%
26,475 $918,000
Q2 2019

Aug 14, 2019

BUY
$19.91 - $28.97 $14,434 - $21,003
725 New
725 $21,000
Q1 2019

May 10, 2019

SELL
$18.84 - $21.36 $3,202 - $3,631
-170 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$17.1 - $23.55 $3,078 - $4,239
-180 Reduced 51.43%
170 $3,000
Q2 2018

Aug 10, 2018

SELL
$14.65 - $23.75 $2,007 - $3,253
-137 Reduced 28.13%
350 $8,000
Q1 2018

May 09, 2018

BUY
$14.4 - $16.8 $806 - $940
56 Added 12.99%
487 $7,000
Q4 2017

Feb 14, 2018

BUY
$15.3 - $17.4 $4,329 - $4,924
283 Added 191.22%
431 $0
Q3 2017

Nov 13, 2017

BUY
$13.7 - $15.65 $2,027 - $2,316
148
148 $2,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $582M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.